Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

17.23

-0.32 (-1.82%)

At close: Jun 26, 2026, 4:00 PM EDT

17.27

+0.04 (0.23%)

After-hours: Jun 26, 2026, 7:56 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	298.3	283.06	235.13	175.51	134.03	45.61
Revenue Growth (YoY)	20.62%	20.38%	33.97%	30.95%	193.89%	-9.01%
Cost of Revenue	30.6	32.67	28.25	14.15	5.66	1.09
Gross Profit	267.7	250.39	206.89	161.37	128.37	44.51
Selling, General & Admin	103.48	101.79	172.03	195.04	196.37	173.54
Research & Development	34.23	32.51	20.79	49.64	44.99	51.14
Other Operating Expenses	5.49	11.18	18.76	8.38	-1.52	0.57
Total Operating Expenses	143.21	145.48	211.57	253.06	239.84	225.25
Operating Income	124.49	104.91	-4.69	-91.69	-111.47	-180.74
Interest Income	13.52	13.57	16.97	17	5.12	0.53
Interest Expense	-4.28	-4.33	-4.84	-2.78	-	-
Total Non-Operating Income (Expense)	9.24	9.24	12.14	14.22	5.12	0.53
Pretax Income	133.73	114.16	7.45	-77.47	-106.35	-180.21
Provision for Income Taxes	-164.48	-173.05	1.7	0.55	1.83	0.76
Net Income	298.21	287.2	5.75	-78.02	-108.18	-180.97
Net Income to Common	298.21	287.2	5.75	-78.02	-108.18	-180.97
Net Income Growth	648.43%	4893.08%	-	-	-	-
Shares Outstanding (Basic)	133	134	143	143	142	129
Shares Outstanding (Diluted)	138	139	146	143	142	129
Shares Change (YoY)	-5.03%	-5.13%	2.07%	0.93%	9.70%	9.20%
EPS (Basic)	2.26	2.14	0.04	-0.54	-0.76	-1.40
EPS (Diluted)	2.17	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	675.00%	5075.00%	-	-	-	-
Free Cash Flow	166.64	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	23.07%	206.99%	-	-	-	-
Free Cash Flow Per Share	1.21	0.98	0.30	-0.24	-0.56	-1.22
Gross Margin	89.74%	88.46%	87.99%	91.94%	95.77%	97.61%
Operating Margin	41.73%	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Profit Margin	99.97%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
FCF Margin	55.87%	47.84%	18.76%	-19.47%	-59.55%	-346.44%
EBITDA	143.9	124.36	14.76	-80.04	-108.76	-177.97
EBITDA Margin	48.24%	43.94%	6.28%	-45.61%	-81.15%	-390.25%
EBIT	124.49	104.91	-4.69	-91.69	-111.47	-180.74
EBIT Margin	41.73%	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Effective Tax Rate	-122.99%	-151.58%	22.77%	-0.71%	-1.72%	-0.42%

SEC Filings: 10-K · 10-Q